How are medicine and pharmaceuticals becoming part of public policy? What factors influence the formation of global ...

Companies see a commercial opportunity in creating new ways to administer drugs to patients – in space.

Pharma is employing AI to support approval submissions by predicting how regulators will react before data is submitted.

The Pulse Report highlights AI’s growing role in preclinical and translational development as biopharma companies seek ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

ST. GALLEN, Switzerland & PALMA, Spain & ZURICH--(BUSINESS WIRE)--Regulatory News: “We are gaining momentum with our ambitious strategic growth plans as we today add Sanifit, Inositec and their ...

Neuland Laboratories will invest $20 million to open a dedicated process-development laboratory and integrated kilo lab at ...

Cancer drug development has never moved faster. Yet, for too many patients, the next treatment decision still begins with ...

Partnerships in healthcare have never been more important. Through collaboration, industry specialists are increasingly bringing cutting-edge medical innovations and life-changing treatments to ...

Silo Pharma, Inc., a biopharmaceutical company focused on developing innovative treatments for mental health and chronic pain, announced in a recent letter to shareholders that it expects to submit an ...

Royalty Pharma plc has completed a transaction to monetize remaining fixed payments on the MorphoSys Development Funding Bonds for $511 million in cash, resulting in total proceeds of $530 million ...

One company posts rapid revenue growth but remains unprofitable, while the other boasts global scale and steady cash flow.